Comparison of E test and agar dilution for testing activity of ceftriaxone against Neisseria gonorrhoeae

Journal of Medical Microbiology

Volumn 65, Issue 7, 2016, Pages 701-702

  Shende, Trupti ^a   Sood, Seema ^a   Singh, Rajendra ^a   Kapil, Arti ^a   Kar, H K ^b   Sharma, V K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Agar dilution method; Ceftriaxone; E test; Minimum inhibitory concentrations (MICs); Neisseria gonorrhoeae

Indexed keywords

CEFTRIAXONE; ANTIINFECTIVE AGENT;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISK DIFFUSION; EPSILOMETER TEST; GOLD STANDARD; INTERMETHOD COMPARISON; LETTER; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG EFFECTS; EVALUATION STUDY; HUMAN; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 84980349629     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000283     Document Type: Letter

References (12)

1. Bala, M., Kakran, M., Singh, V., Sood, S., Ramesh, V. and Members of the WHO GASP SEAR Network (2013). Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infec 89, iv28-iv35.
2. Bell, S. M., Pham, J. N., Carter, I. W. and Hanrahan, J. K. (2011). Antibiotic Susceptibility Testing by the CDS Method. A Manual for Medical and Veterinary Laboratories, 6th edn. Randwick, NSW: South Eastern Area Laboratory Services.
3. CDC (2015). Sexually transmitted diseases treatment guidelines. MMWR 64, 1-140.
4. CLSI (2012). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, 9th edn, M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Ison, C., Hussey, J., Sankar, K., Evans, J. and Alexander, S. (2011). Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 16, 19833.
6. Lahra, M. M., Ryder, N. and Whiley, D. M. (2014). A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med 371, 1850-1851.
7. Martin, I. M., Hoffmann, S., Ison, C. A. and ESSTI Network (2006). European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 58, 587-593.
8. Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S., Kitawaki, J. and Unemo, M. (2011). Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with highlevel resistance to ceftriaxone. Antimicrob Agents Chemother 55, 3538-3545.
9. Sood, S., Mahajan, N., Verma, R., Kar, H. K. and Sharma, V. K. (2013). Emergence of decreased susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae in India. Natl Med J India 26, 26-28.
10. U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Devices and Radiological Health (2009). Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) System, Rockville, MD. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080564.
11. Unemo, M., Fasth, O., Fredlund, H., Limnios, A. and Tapsall, J. (2009). Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 63, 1142-1151.
12. Unemo, M., Golparian, D., Syversen, G., Vestrheim, D. F. and Moi, H. (2010). Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 15, 19721.